PRESS RELEASES
Medical Microinstruments Participates in the “Minimally Invasive Robotic Surgery Systems (TREMIRS)” Project
Project co-funded by the European Regional Development Fund (ERDF) and the Consejería de Economía, Ciencia y Agenda Digital of Govern of Extremadura
PISA, Italy, June 8, 2022 – Medical Microinstruments (MMI), a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced that it will participate in “THE MINIMALLY INVASIVE ROBOTIC SURGERY SYSTEMS project (TREMIRS), REFERENCE: CPI-2019-33-1-TRE-14, in the framework of the Line for the Promotion of Innovation from the Demand for the Public Purchase of Innovation (FID-CPI Line) of the Ministry of Science and Innovation and a total budget of 7,345,300.00 €, has been co-funded (80%) by the European Regional Development Fund through a grant given by the Regional Ministry of Economy, Industry and Tourism (5.876.240,00€) and co-funded (20%) by Consejería de Economía, Ciencia y Agenda Digital of Govern of Extremadura (1.469.060,00€).”
TREMIRS aims to improve the currently available surgical robotic systems for both laparoscopy and microsurgery to offer better solutions for patients, improved ergonomics for surgeons and greater performance for surgical teams to ultimately improve the quality of care. There are two aspects of this project: (1) The development of a robotic platform for laparoscopic surgery that addresses the limitations of current robotic laparoscopic surgery systems available on the market, and (2) the development of a teleoperated robotic platform for reconstructive microsurgery, consisting of robotic micro-instruments with high maneuverability and precision.
Together with Jesús Usón Minimally Invasive Surgery Centre (Spain), MMI will address the 2nd part of the project related to advancing a Robotic platform for microsurgery. The project will focus on specific improvements to the Symani® Surgical System, which received CE mark in November of 2019, and the development of additional NanoWrist® Instruments.
About MMI
Medical Microinstruments (MMI) was founded in 2015 near Pisa, Italy to enhance surgical performance through the development of a robotic system that enables surgeons to achieve better outcomes in microsurgery. The Symani Surgical System combines proprietary innovations including the world’s smallest wristed microinstruments as well as tremor-reducing and motionscaling technologies. Together, these powerful capabilities allow more surgeons to successfully perform microsurgery while expanding the field of supermicrosurgery. MMI is backed by international medtech investors including Andera Partners, Panakes Partners, Fountain Healthcare Partners and Sambatech.
Related News
MMI Wins FDA Clearance and Completes First U.S. Clinical Use of Robotic Microsurgical Dissection Instruments with Symani
MMI Announces CPT Code and CMS Reimbursement for Robotic Lymphatic Surgery, Unlocking Market Access and Growth Potential
Leading New Jersey hospital treats first patient with new robotic surgical approach to manage symptoms of breast-cancer related lymphedema
MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
MMI Enrolls First Patient in Landmark U.S. Clinical Study Advancing Robotic Microsurgery
MMI Completes World’s First Robotic Microsurgical Intracranial Brain Surgery
MMI CEO Mark Toland on How the Symani Surgical System Is Redefining Robotic Microsurgery
World-first robotic throat surgery at Melbourne hospital saves patient’s voice and ability to eat
MMI’s Symani® System Redefines Robotic Microsurgery Again with First-Ever Dissection and Digital Surgery Capabilities
MMI to Present at 43rd Annual J.P. Morgan Healthcare Conference
Cedars-Sinai secures research funding to develop eye transplantation procedures to cure blindness
